Brandinium

Trademark search for:

EMERALD THERAPEUTICS

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2014-07-28 — Application filed
  • 2014-07-31 — Application filed
  • 2014-08-05 — Application filed
  • 2014-11-10 — Assigned to examiner
  • 2014-11-12 — Notification of examiners amendment e-mailed
  • 2014-11-12 — Examiners amendment e-mailed
  • 2014-11-12 — Examiners amendment -written
  • 2014-11-12 — Examiner's amendment entered
  • 2014-11-17 — Approved for pub - principal register
  • 2014-12-04 — Assigned to lie
  • 2014-12-08 — Law office publication review completed
  • 2014-12-24 — Notification of notice of publication e-mailed
  • 2015-01-13 — Published for opposition
  • 2015-01-13 — Official gazette publication confirmation e-mailed
  • 2015-01-26 — Teas change of owner address received
  • 2015-01-26 — Applicant/correspondence changes (non-responsive) entered
  • 2015-03-10 — Noa e-mailed - sou required from applicant
  • 2015-09-01 — Sou teas extension received
  • 2015-09-01 — Sou extension 1 filed
  • 2015-09-01 — Sou extension 1 granted
  • 2015-09-03 — Notice of approval of extension request e-mailed
  • 2016-02-29 — Sou teas extension received
  • 2016-02-29 — Sou extension 2 filed
  • 2016-03-30 — Case assigned to intent to use paralegal
  • 2016-03-30 — Case assigned to intent to use paralegal
  • 2016-04-01 — Sou extension 2 granted
  • 2016-04-02 — Notice of approval of extension request e-mailed
  • 2016-08-15 — Teas statement of use received
  • 2016-08-15 — Teas request to divide received
  • 2016-08-15 — Divisional request received
  • 2016-08-15 — Use amendment filed
  • 2016-08-26 — Divisional processing complete
  • 2016-08-26 — Statement of use processing complete
  • 2016-08-27 — Allowed principal register - sou accepted
  • 2016-08-30 — Notice of acceptance of statement of use e-mailed
  • 2016-10-04 — Registered-principal register
  • 2016-12-07 — Automatic update of assignment of ownership
  • 2017-03-01 — Automatic update of assignment of ownership
  • 2021-10-04 — Courtesy reminder - sec. 8 (6-yr) e-mailed
  • 2022-04-15 — Attorney/dom.rep.revoked and/or appointed
  • 2022-04-15 — Teas change of correspondence received
  • 2022-04-15 — Teas revoke/app/change addr of atty/dom rep received
  • 2023-04-14 — Cancelled sec. 8 (6-yr)
  • 2023-04-14 — Final status recorded

Owner Information

EMERALD THERAPEUTICS, INC.
SOUTH SAN FRANCISCO , CA
EMERALD CLOUD LAB, INC.
SOUTH SAN FRANCISCO , CA
Emerald Therapeutics, Inc.
South San Francisco , CA
Emerald Therapeutics, Inc.
South San Francisco , CA
Emerald Therapeutics, Inc.
Menlo Park , CA

Correspondent

Harold Milstein Sheppard Mullin Richter & Hampton LLP
1540 El Camino Real, Suite 120
Menlo Park, CA 94025
UNITED STATES

Filing Details

Filing Date:
2014-07-28
Status Date:
2023-04-14
Filing Year:
2014

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.